Pancreatic Cancer Research

ResearcherUniversity of Alabama at BirminghamActive in the last 2 years

Chandler A. Annesi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6361-9842; OpenAlex author ID A5074066194. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2025: 2 papers · 2026: 1 paper

Papers 3

  1. Leveraging large language models to automate scoping reviews: A case study in treatment options for pancreatic cancer. Co-author DOI 10.1016/j.amjsurg.2025.116764↗
  2. Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: A Systemic Review and Meta-Analysis. Co-author DOI 10.1016/j.jss.2025.04.042↗
  3. Corrigendum to 'Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: A Systemic Review and Meta-analysis' Jou… Co-author DOI 10.1016/j.jss.2025.10.015↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Annabelle L. Fonseca · 3 shared papers, 2025–2026 · strength 0.85
  2. John Bart Rose · 2 shared papers, 2025 · strength 0.54
  3. Sushanth Reddy · 2 shared papers, 2025 · strength 0.54
  4. Michelle M. Holland · 2 shared papers, 2025 · strength 0.54
  5. Martin J. Heslin · 2 shared papers, 2025 · strength 0.54
  6. Vikas Dudeja · 2 shared papers, 2025 · strength 0.54
  7. Manish Tripathi · 1 shared paper, 2026 · strength 0.32

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.